ARKG News and Press, ARK Genomic Revolution ETF From 01/08/26

2026-01-08 05:30:00 ET After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk...

2026-01-05 07:20:16 ET More on ARK Invest ARKW: Fourth Quarter Retreat May Preview A Volatile 2026 ARKK: Heads You Don't Win, Tails You Lose QQQ Vs. ARKK: The Critical Role Of Equity Duration In Growth Investing From record highs to record outflows: Bitcoin E...

2025-12-29 08:15:02 ET More on ARK Invest ARKK: Heads You Don't Win, Tails You Lose QQQ Vs. ARKK: The Critical Role Of Equity Duration In Growth Investing ARKX: Aerospace And Defense Are Set Up For High Growth In 2026 Cathie Wood's weekly recap: boots bets on...

2025-12-22 06:30:23 ET More on ARK Invest ARKK: Heads You Don't Win, Tails You Lose QQQ Vs. ARKK: The Critical Role Of Equity Duration In Growth Investing ARKX: Aerospace And Defense Are Set Up For High Growth In 2026 Cathie Wood buys the dip: Ark Invest load...

2025-12-19 03:10:00 ET By Frank Coughlin A clear story has emerged from the third quarter earnings season - one of divergence. We are seeing a market split between companies benefiting from major secular growth trends and those navigating more traditional economic cycles.... ...

2025-12-15 07:00:44 ET More on ARK Invest ARKQ: Rising Robotics Tide Lifts All Boats Temporarily, I Prefer The Options Route Here ARKX: Aerospace And Defense Are Set Up For High Growth In 2026 My Prediction: Back To All Time Highs Before Year End Cathie Wood'...

2025-12-08 05:22:02 ET Read the full article on Seeking Alpha For further details see: Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names

2025-12-06 01:25:00 ET ... Read the full article on Seeking Alpha For further details see: Why An Investment Process Matters, Especially In Volatile Markets

2025-12-04 10:29:50 ET Crispr Therapeutics AG ( CRSP ) was founded in 2013 and is based in Zug, Switzerland. It is the market leader in transformative therapies incorporating CRISPR/Cas9 technology, solidifying its position after receiving approval by the FDA (Dec 2023) & EMA (F...

2025-12-02 03:18:00 ET November offered a reminder that even in a market defined by powerful structural themes, the path forward is seldom linear. US equities ended the month mixed, with the S&P 500 and Dow posting modest gains, while the Nasdaq registered its first monthly decline ...